Oxidative stress in heart failure: what are we missing?

Area of Science:

• Cardiology
• Molecular Biology
• Biochemistry

Background:

• Oxidative stress is elevated in heart failure (HF), contributing to disease progression.
• Cardiac myocytes' high metabolic activity generates reactive oxygen species, exacerbating HF.
• Oxidative stress triggers detrimental processes like altered gene expression and cell death in myocardial remodeling.

Purpose of the Study:

• To review the role of oxidative stress in heart failure.
• To explore why antioxidant strategies have failed to translate into effective HF therapeutics.
• To discuss potential reasons for the lack of clinical success of antioxidants in HF.

Main Methods:

• Review of existing human and animal model studies on oxidative stress in HF.
• Analysis of cellular and molecular mechanisms linking oxidative stress to myocardial remodeling.
• Evaluation of antioxidant efficacy in preclinical HF models versus clinical trial outcomes.

Main Results:

• Animal models show antioxidants can prevent HF progression and improve cardiac function.
• Despite promising preclinical data, no antioxidant strategy has proven effective in human HF patients.
• Evidence suggests oxidative stress significantly contributes to HF pathogenesis.

Conclusions:

• The failure of antioxidants in clinical HF trials necessitates a re-evaluation of current therapeutic strategies.
• Potential reasons for failure include misunderstanding key reactive oxygen species sources, suboptimal antioxidant choices, or insufficient understanding of individual antioxidant variability.
• Further research is needed to identify effective antioxidant approaches for human heart failure.